Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Kailos

Kailos
2010 FOUNDED
PRIVATE STATUS
11-20 EMPLOYEES
Later Stage VC LATEST DEAL TYPE (In Progress)
$1.98M LATEST DEAL AMOUNT
4 INVESTORS
Description

Provider of laboratory solutions for next generation sequencing including matched reagents with informatic solutions for analysis and reporting and reference lab services. The company's laboratory information systems includes modules for managing samples in laboratory environments , analytics and full reporting, enabling less sophisticated and very knowledgeable labs to launch NGS clinical assays.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Services
Other Healthcare Technology Systems
Primary Office
  • 601 Genome Way
  • Huntsville, AL 35806
  • United States

+1 (866) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Kailos’s full profile, request a free trial.

Kailos Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 17-Apr-2018 $1.98M 0000 In Progress Generating Revenue
6. Later Stage VC (Series C) 11-Jul-2017 0000 0000 0000 Completed Generating Revenue
5. Later Stage VC (Series B) 18-Jul-2016 00.00 000 000.00 Completed Generating Revenue
4. Grant 22-Jun-2016 00.00 00.00 Completed Generating Revenue
3. Early Stage VC 26-Aug-2015 000 Cancelled Generating Revenue
2. Early Stage VC (Series A) 16-Dec-2011 $3.5M $3.5M 00.00 Completed Startup
1. Grant Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Kailos Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series C 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series B 0,000,000 00.000000 00.00 00.00 00 00.00 0.000
Series A 3,444,897 $0.001000 $1 $1 1x $1 10.5%
To view this company’s complete Cap Table, request access »

Kailos Competitors (30)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
GnuBIO Formerly VC-backed Cambridge, MA 00 0000 000000&0 0000
000000 00000000 00 Private Equity-Backed Oxford, United Kingdom 000 00000 000000000
000000000000 Formerly VC-backed Carlsbad, CA 000 000.00 000000&0 000.00
00000000 000-00000 Corporate Backed or Acquired Fremont, CA 00 000.00 000000&0 000.00
00000000 Venture Capital-Backed Boulder, CO 000 000.00 00000000000 000.00
To view this company’s complete list of competitors, request access »

Kailos Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
In-Q-Tel Not-For-Profit Venture Capital Minority 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
New Capital Partners PE/Buyout Minority 000 0000 000000 0
Alabama Launchpad Not-For-Profit Venture Capital 000 0000 000000 0

Kailos Executive Team (4)

Name Title Board
Seat
Contact
Info
Brian Pollock Co-Founder, Chief Executive Officer, President and Board Member
Cheri Walker Ph.D Chief Financial Officer & Senior Vice President, Corporate Development
Randall Bachmeyer Ph.D Chief Technology Officer & Co-Founder
Troy Moore Co-Founder, Chief Scientific Officer & Board Member

Kailos Board Members (6)

Name Representing Role Since Contact
Info
Danny Windham Self Board Member 000 0000
James Hudson Jr. Self Board Member 000 0000
Katherine Varley Ph.D Self Board Member 000 0000
Michael Walters Kailos Co-Founder & Board Member 000 0000
Troy Moore Kailos Co-Founder, Chief Scientific Officer & Board Member 000 0000

1 Former Board Member

You’re viewing 5 of 6 board members. Get the full list »